In recognition of National Hispanic Heritage Month The Association of Clinical Resrarch Professionals (ACRP) reached out to some cultural communications professionals to discuss the importance of clear communications between study teams and participants in clinical trials, no matter what their native languages may be....
Experts say a wider diverse pool of patients needs to be given a chance to participate in clinical research to get rare disease drugs faster to market....
Sponsors can employ several postmarketing strategies to beef up safety and efficacy data on populations that were under-represented in initial clinical trials of drugs and biologics, according to new draft guidance issued by the US Food and Drug Administration (FDA)....
Betsy Nugent, chief clinical research officer at the UW School of Medicine and Public Health and UW Health, appeared on Wisconsin Public Radio to discuss clinical trials at UW-Madison, including the importance of trials, how they operate, and the critical need to increase the diversity...
Researchers discovered race/ethnicity underrepresentation during an analysis of over 100 dermatology-focused clinical trials....
It is impossible to view a trial as being of high quality without adequate representation of all patient populations....
In this interview, Mabel Peters, who works with the UW Clinical Research Office as a clinical trials liaison, discusses her career path, and why diverse participation is so critical to the success of clinical trials....
Increased diversity in clinical trials should be a requirement, not a suggestion....
Achieving clinical trial diversity will require a multi-stakeholder approach across the healthcare ecosystem, including efforts by government agencies, health systems, and industry....
While the use of digital health technologies has increased in clinical trials, securing patients' trust continues to be a significant challenge. These technologies may help build trust by helping to increase representation in clinical trials....
